Cargando…
Abstract 1657: Design and Evaluation of Buforin II Variants with Enhanced DNA Binding and Antimicrobial Activity
Autores principales: | Kim, Gabriela, Li, Qiao, Jing, Lisha, Radhakrishnan, Mala, Elmore, Donald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Biochemistry and Molecular Biology, Inc. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100282/ http://dx.doi.org/10.1016/j.jbc.2023.103106 |
Ejemplares similares
-
Abstract 1647: Quantification of functional antibody titers in a mouse model of SARS-CoV-2 infection
por: Hernandez, Dulce, et al.
Publicado: (2023) -
Abstract 2706: AMR Enzymatic inactivation mechanism attributed to fosA Gene antibiotic resistance among Covid 19 hospitalized patients
por: Aly, Mahmoud
Publicado: (2023) -
Abstract 1569: Assessing the Cholinergic Anti-Inflammatory Response in Human Macrophages Exposed to the Spike Protein of the SARS-CoV-2 Strain from Wuhan, China
por: Irizarry-Alvarez, Randy, et al.
Publicado: (2023) -
Abstract 2663: Rising level of pulmonary dioxin might trigger CMV and HSV-1 reactivation via bHLH/PAS/AhR:ARNT transcription pathway in lungs of immunocompetent COVID-19 patients with ARDS
por: Tsyrlov, Ilya, et al.
Publicado: (2023) -
Electrostatics-Based
Computational Design and Experimental
Analysis of Buforin II Antimicrobial Peptide Variants with Increased
DNA Affinities
por: Li, Qiao, et al.
Publicado: (2023)